Avian Coryza in Chickens: Etiology, Epidemiology, Clinical Signs, Pathology, Diagnosis, and Control

Introduction

Avian coryza, also known as infectious coryza, is an acute to subacute upper respiratory disease of chickens primarily caused by the bacterium Avibacterium paragallinarum (formerly Haemophilus paragallinarum). The disease is characterized by catarrhal inflammation of the nasal passages, sinuses, and conjunctiva, leading to significant economic losses in commercial poultry operations due to reduced growth rates, decreased egg production, and increased culling rates [1]. This article provides a comprehensive, clinically oriented review of avian coryza, with a focus on its etiology, pathogenesis, clinical presentation, diagnostic methodologies, and evidence-based control strategies.

Etiology and Taxonomy

The causative agent of avian coryza is Avibacterium paragallinarum, a Gram-negative, non-motile, pleomorphic coccobacillus belonging to the family Pasteurellaceae. Historically classified under the genus Haemophilus, the organism was reclassified into the genus Avibacterium based on phylogenetic analyses of 16S rRNA gene sequences [1]. A. paragallinarum is a fastidious, capnophilic bacterium requiring nicotinamide adenine dinucleotide (NAD, V factor) for in vitro growth, but not hemin (X factor). This NAD requirement is a key phenotypic trait used for its identification.

The species is divided into three serovars (A, B, and C) based on the Page scheme, with additional serogroups identified through more recent molecular typing methods [2]. Serovar A is most commonly associated with outbreaks in commercial layers and broilers worldwide, while serovar C is also prevalent. Serovar B is less frequently isolated but can cause disease. The serovar designation is critical for vaccine development, as protection is predominantly serovar-specific. Strains may also vary in virulence, with some producing only mild catarrhal inflammation while others induce severe fibrinous sinusitis and conjunctivitis [3].

Epidemiology

Avian coryza occurs globally, with higher prevalence in regions with intensive poultry production and multi-age flock management. The disease is most commonly reported in commercial layers, broiler breeders, and occasionally in broilers, particularly in flocks with suboptimal biosecurity [4]. The primary reservoir is infected chickens and, less commonly, turkeys. A. paragallinarum is a fragile bacterium that does not survive long outside the host; transmission is almost exclusively horizontal via direct contact, aerosol droplets, or contaminated fomites (e.g., feed, water, personnel, equipment) [5]. The incubation period ranges from 1 to 3 days under experimental conditions, but may extend to 7 days in field situations depending on infectious dose and host immune status [6].

Carrier birds, which may harbor the organism in the nasal sinuses for weeks to months after clinical recovery, are the primary source of infection within and between flocks [7]. Stressors such as overcrowding, poor ventilation, concurrent infections (e.g., Mycoplasma gallisepticum, Escherichia coli, infectious bronchitis virus), and nutritional deficiencies exacerbate disease severity and transmission rates [8].

Pathogenesis and Pathology

Following inhalation or direct contact, A. paragallinarum colonizes the epithelial cells of the upper respiratory tract, specifically the nasal mucosa and sinus epithelium. The bacterium possesses several virulence factors, including a polysaccharide capsule that inhibits phagocytosis, fimbriae for adherence, and a cytotoxin that induces ciliostasis and epithelial cell destruction [9]. The host inflammatory response, characterized by infiltration of heterophils and macrophages, leads to the accumulation of serous to mucopurulent exudate within the nasal passages and infraorbital sinuses.

Gross pathological findings are largely confined to the upper respiratory tract. Typical lesions include catarrhal to purulent rhinitis, sinusitis with caseous exudate in the infraorbital sinuses, and conjunctivitis. In severe cases, the exudate may become inspissated, forming caseous plugs within the sinuses and nasal passages [10]. Secondary bacterial infections, particularly with Escherichia coli or Ornithobacterium rhinotracheale, can result in fibrinous airsacculitis, pericarditis, and perihepatitis, complicating the gross pathology [11]. Histologically, there is epithelial hyperplasia, deciliation, and a mixed inflammatory cell infiltrate in the lamina propria.

Clinical Signs

The clinical presentation of avian coryza varies with the virulence of the A. paragallinarum strain, host age, immune status, and presence of concurrent infections. The classic syndrome includes:

• Ocular signs: Serous to mucopurulent conjunctivitis, periorbital edema, and frothy ocular discharge.
• Nasal signs: Profuse serous to purulent nasal discharge, sneezing, and rales.
• Facial edema: Swelling of the infraorbital sinuses and periorbital region, often unilateral initially.
• Respiratory signs: Tracheal rales, coughing, and dyspnea in severe cases.
• Systemic signs: Anorexia, depression, reduced water and feed intake, and a marked drop in egg production (10–40%) in laying flocks [12].

Morbidity is typically high (up to 80–100%), while mortality is generally low (1–5%) unless complicated by secondary pathogens or environmental stressors [13]. In broilers, the disease primarily impairs weight gain and feed conversion, while in layers, the primary economic impact is the decline in egg production and increased mortality from secondary infections.

Differential Diagnosis

The clinical presentation of avian coryza overlaps with several other respiratory diseases of poultry. A thorough differential diagnosis must consider:

• Avian influenza (low pathogenicity strains): May present with similar respiratory signs but often has higher mortality and systemic involvement.
• Newcastle disease (lentogenic strains): Respiratory signs with occasional neurological signs.
• Infectious bronchitis: Characterized by tracheal rales, nephritis in some strains, and a rapid spread.
• Mycoplasmosis (Mycoplasma gallisepticum): Chronic respiratory disease with airsacculitis; often co-infects with A. paragallinarum.
• Fowl cholera (Pasteurella multocida): Acute septicemic form with high mortality; chronic form may present with swollen wattles and sinuses.
• Avian metapneumovirus infection: Causes swollen head syndrome, which can mimic coryza.

Laboratory confirmation is essential due to the clinical overlap with these pathogens [11].

Diagnostic Approaches

Definitive diagnosis of avian coryza relies on the isolation and identification of A. paragallinarum from clinical specimens, supported by molecular or serological methods.

Sample Collection and Transport

Swabs from the infraorbital sinuses, nasal passages, or trachea are the preferred specimens. Because A. paragallinarum is highly fastidious, samples should be collected from acutely affected birds and transported in a suitable transport medium (e.g., Amies medium with charcoal) and processed within 24 hours. Refrigeration (4°C) is acceptable for short-term storage, but freezing without cryoprotectant is detrimental [4].

Culture and Isolation

The organism requires NAD (V factor) for growth and does not require hemin (X factor). Selective media, such as chocolate agar supplemented with 1% IsoVitaleX or a feeder streak of Staphylococcus aureus (satellitism phenomenon), are used. Incubation is performed at 37°C in a 5–10% CO₂ atmosphere for 24–48 hours. Colonies are small, dewdrop-like, and may produce a characteristic "satellite" pattern around a nurse colony. Biochemical identification includes catalase positivity, oxidase positivity, and the ability to reduce nitrate. Carbohydrate fermentation profiles (e.g., glucose, maltose) help differentiate A. paragallinarum from other Avibacterium species [5].

Molecular Diagnostics

Polymerase chain reaction (PCR) assays targeting the HMTp210 gene (encoding a hemagglutinin-like protein) are now the gold standard for rapid and specific detection of A. paragallinarum directly from clinical samples or bacterial isolates [6]. Multiplex PCR panels can simultaneously detect A. paragallinarum, Mycoplasma gallisepticum, Mycoplasma synoviae, and Ornithobacterium rhinotracheale, facilitating comprehensive respiratory disease diagnosis. Quantitative real-time PCR (qPCR) allows for bacterial load estimation, which can correlate with disease severity [7].

Serological Testing

Serological assays, including the hemagglutination inhibition (HI) test and enzyme-linked immunosorbent assay (ELISA), are used for flock-level surveillance. The HI test is serovar-specific and requires standardized antigens. ELISA kits offer higher throughput but may have variable sensitivity across serovars. Serology is most useful for confirming exposure in unvaccinated flocks or for monitoring vaccine responses [8].

Pathology and Histopathology

At necropsy, typical findings include:

• Catarrhal to purulent exudate in the nasal passages and infraorbital sinuses.
• Swelling and hyperemia of the nasal mucosa and conjunctiva.
• In chronic or complicated cases, caseous sinusitis, airsacculitis, and pneumonia may be present. Histologically, there is epithelial hyperplasia, loss of cilia, and infiltration of heterophils and mononuclear cells in the lamina propria [10].

Treatment and Antimicrobial Therapy

Treatment of avian coryza is primarily aimed at reducing clinical signs and limiting secondary infections. Antimicrobial therapy should be guided by in vitro susceptibility testing due to the emergence of resistance. Commonly used antimicrobials include tetracyclines (e.g., doxycycline, oxytetracycline), sulfonamides (e.g., sulfadimethoxine), and macrolides (e.g., tylosin, tilmicosin) [12]. Water-soluble formulations are preferred for mass medication. However, treatment often fails to eliminate the carrier state, and recovered birds may remain infectious [5].

Antimicrobial Resistance

Resistance to tetracyclines and sulfonamides has been reported in several regions, necessitating periodic surveillance. The use of fluoroquinolones in poultry should be restricted due to public health concerns regarding antimicrobial resistance [13].

Control and Prevention

Biosecurity

Strict biosecurity is the cornerstone of prevention. All-in/all-out management, cleaning and disinfection of facilities between flocks, control of personnel and equipment movement, and prevention of contact with wild birds or other poultry are critical. A. paragallinarum is susceptible to common disinfectants, including quaternary ammonium compounds and bleach [8].

Vaccination

Inactivated (bacterin) vaccines are widely used in commercial layers and breeders. These vaccines are typically multivalent, containing two or three serovars (A, B, and C) to provide broad protection. Vaccination is administered via subcutaneous or intramuscular injection, usually at 6–10 weeks of age, with a booster 4–6 weeks later. While vaccination reduces clinical signs and egg production losses, it does not prevent infection or the carrier state entirely [9]. Autogenous vaccines may be prepared from field isolates when serovar diversity is a concern.

Management

Improved ventilation, reduced stocking density, and elimination of concurrent infections (e.g., mycoplasmosis, colibacillosis) are critical to reducing disease severity. Eradication from a flock is difficult due to the carrier state; depopulation and thorough cleaning followed by a downtime period of 2–4 weeks is recommended for breeder flocks [10].

Differential Diagnosis

Avian coryza must be differentiated from other respiratory diseases of poultry. Key distinguishing features include the pronounced facial edema and sinusitis, which are less common in infectious bronchitis or Newcastle disease. Laboratory confirmation is essential, as clinical signs alone are not pathognomonic. The table below summarizes the key differentials.

Differential Diagnosis

Avian coryza must be differentiated from other causes of upper respiratory disease in chickens. Key differentiating features include the rapid onset of facial edema and sinusitis, the absence of neurological signs (unlike Newcastle disease), and the lack of high mortality typical of acute fowl cholera. Laboratory confirmation via PCR or culture is essential, as mixed infections are common [11].

Conclusion

Avian coryza remains a significant bacterial disease of poultry worldwide, causing substantial economic losses through reduced egg production, increased culling, and treatment costs. Successful control requires accurate diagnosis, implementation of robust biosecurity measures, strategic vaccination with appropriate serovars, and prudent antimicrobial use. Integrated management that addresses environmental stressors and concurrent infections is essential for minimizing the impact of this disease in commercial poultry operations.

References

[1] Blackall PJ, Christensen H, Beckenham T, et al. Reclassification of Haemophilus paragallinarum as Avibacterium paragallinarum gen. nov., comb. nov. Int J Syst Evol Microbiol. 2005;55(1):353-362.

[2] Soriano EV, Blackall PJ. Av